Skip to main content
. 2020 Oct 25;21(21):7923. doi: 10.3390/ijms21217923

Table 2.

Pet tracers of neuroinflammation.

Tracer and Radioisotope Target Tested in Notes References
[11C]-(R)-PK11195 TSPO human ALS patients and healthy controls signals are not influenced by patient’s TSPO genotype [103,131]
rat model of cerebral ischemia (Wistar rats) poor specificity
[18F]DPA-714 TSPO ALS model (SOD1G93A mouse) signals correlate to increased TSPO expression and compromised brain regions [87,131]
rat model of cerebral ischemia (Wistar rats) higher affinity and better signal-to-noise ratio than PK11195
[11C]-PBR28 TSPO human ALS, PLS patients and healthy controls signals correlate to glial activation and inflammation [102,132]
human healthy subjects binding is affected by TSPO polymorphism
[11C]A-836339 CB2 neuroinflammation-induced/AD models (CD-1 and APPswe/PS1ΔE9 mouse) first CB2 radiotracer tested [123,124]
AD model (APPswe/PS1ΔE9 mouse) detection of neuroinflammation very early in the pathology
[11C]NE40 CB2 AD, PD patients and healthy controls no differences between disease and control cases [127,128,133]
ischemic stroke model (Sprague–Dawley rat) signal in peri-infarct area, concomitant to CB2 up-regulation
senescence-accelerated model (SAMP10 mouse) detection of early signs of neuroinflammation in cortex
[11C]KD2 CB2 ALS patients selective binding in post-mortem ALS spinal cord specimens [129,134]
neuroinflammation-induced model (CD-1 mouse) limited target specificity and excessive lipophilicity
[11C]RS-016 CB2 neuroinflammation-induced model (CD-1 mouse) high blood stability and CB2 specificity [134]
ALS patients selective binding in post-mortem ALS spinal cord specimens
[18F]29 CB2 neuroinflammation-induced model (CD-1 mouse) CB2 specific tracing but very rapid metabolism [105]
[18F]3 CB2 Wistar rats rapid washout from brain tissue [130]
ALS patients and healthy controls selective binding in post-mortem ALS spinal cord specimens
[11C]GSK1482160 P2X7 neuroinflammation-induced model (C57BL6) increased signals in CNS sites with prominent neuroinflammation [135]